Evidence map›Paper›PMID 33595380›Full record

ReviewExpert opinion on drug metabolism & toxicology2021

Novel test strategies for in vitro seizure liability assessment.

Anke M Tukker, Remco H S Westerink

Abstract readReview
In one paragraph

Review in Expert opinion on drug metabolism & toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Modulation of CaScientific reports · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anke M TukkerSchool of Health Sciences, Purdue University, Hall for Discovery and Learning Research (DLR 339), IN USA.ORCID https://orcid.org/0000-0001-8973-4809
Remco H S WesterinkNeurotoxicology Research Group, Toxicology Division, Institute for Risk Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University, TD Utrecht, The Netherlands.ORCID https://orcid.org/0000-0003-4948-2007

Funding

Manganese exposure susceptibility as a modifier of excitotoxicity in Alzheimer's DiseaseR01ES031401 · NIEHS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOWMAN, AARON B, HARRISON, FIONA EDITH · 2020 to 2024
$2.7M
NIEHS NIH HHS R01 ES031401
6 · The paper itself

Abstract

introductionThe increasing incidence of mental illnesses and neurodegenerative diseases results in a high demand for drugs targeting the central nervous system (CNS). These drugs easily reach the CNS, have a high affinity for CNS targets, and are prone to cause seizures as an adverse drug reaction. Current seizure liability assessment heavily depends on AREAS COVERED: The demand for CNS drugs urges the development of alternative safety assessment strategies. Yet, the complexity of the CNS hampers reliable detection of compound-induced seizures. This review provides an overview of the requirements of EXPERT OPINION: Successful and cost-effective replacement of

Indexed as

Models, BiologicalAnimalsCentral Nervous System AgentsCost-Benefit AnalysisDrug DevelopmentHumansMicroelectrodesPredictive Value of TestsSeizuresCentral Nervous System AgentsAlternatives to animal testingdrug safety assessmentGABAa receptor antagonistshuman-induced pluripotent stem cell (hiPSC)-derived neuronal modelsin vitro seizure liability assessmention channelsmicro-electrode array (MEA) recordingsrodent primary cortical culturessafety pharmacology

Identifiers

PMID33595380
PMCPMC8367052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.